Cargando…
Covid-19-vaccine-pfizer-biontech: Thrombotic thrombocytopenic purpura: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602486/ http://dx.doi.org/10.1007/s40278-021-05621-6 |
Ejemplares similares
-
Covid-19 vaccine pfizer biontech: Immune-mediated thrombotic thrombocytopenic purpura: case report
Publicado: (2021) -
Covid-19-vaccine-pfizer-biontech: Atrial fibrillation and relapse of immune thrombotic thrombocytopenic purpura: case report
Publicado: (2022) -
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
por: Giuffrida, Gaetano, et al.
Publicado: (2021) -
Covid-19-vaccine-pfizer-biontech/levofloxacin: Immune thrombocytopenic purpura: case report
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Immune thrombocytopenic purpura: case report
Publicado: (2021)